Factor XIII High > 150 % (acquired)

Frozen

Packaging options

6-PP13H	Vial	1 x 1.0 mL

Description of the Factor XIII High > 150 % (acquired)

Advantages

Minimize test time. Ready to use.

Informations

Factor XIII is synthesized by the liver. Activated by thrombin, FXIII intervenes in the final phase of fibrinoformation to stabilize the fibrin clot by forming covalent bonds in the fibrin polymer.

product sheet

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

My personal Space

Nouveau client

Factor XIII High > 150 % (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

My personal Space

Nouveau client

Factor XIII High > 150 % (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

Associated products

High Factor II plasma (acquired) > 150 %

High Factor II plasma (G20210A positive mutation) > 150%

High Factor IX plasma > 150 % (acquired)

High Factor V plasma (acquired) > 150 %

High Factor X plasma > 150 % (acquired)

High Factor XI plasma > 150 % (acquired)

High Factor XII plasma > 150 % (acquired)

High FVII plasma 100-150 % (acquired)

High FVIII plasma > 150 % (acquired)